TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,136.48−0.10%Brent$109.04−0.17%BTC$81,787.11−0.28%ETH$2,403.49−0.16%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,136.48−0.10%Brent$109.04−0.17%BTC$81,787.11−0.28%ETH$2,403.49−0.16%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Galectin Therapeutics Inc · Overview · TradingHolo

Markets › United States › NAS › GALT

G

Galectin Therapeutics Inc

NAS:GALTHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$3.62−2.43%At closeAt close · Sat 17 Oct · ≈ AED 13.29 · Market cap $365.08M · Next earnings Fri 13 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−2.4%

1M

−2.4%

3M

−9.5%

6M

+47.8%

1Y

−30.3%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

GALT −2.43% today

✦ This week in three lines

No written digest yet for GALT. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−11.8× vs −1.7×

Price / Book vs sector−2.9× vs 2.0×

Price / Sales vs sector—

Price / Free cash flow vs sector−15.3× vs −1.6×

Forecasts

1 buy0 hold0 sell1 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 84 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All GALT news →

GLGalectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026

GlobeNewswire · 14 d ago

GLGalectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

globenewswire · 40 d ago

GLGalectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update

GlobeNewsWire · 67 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$365.08M

P/E−11.8×

Dividend yield0.0%

52-week range$2.03 – $7.13

Avg volume (20d)210,080

Shares outstanding100,850,000

Beta0.35

Short interest19.4% of float

Next earningsFri 13 Nov

Radar Score

63

Value58

Quality83

Momentum64

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing new therapies for a spectrum of illnesses, including fibrotic disorders and various cancers. The company's flagship therapeutic agent is belapectin (GR-MD-02), an inhibitor of galectin-3,…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%